We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current GANX market cap is 37.31M. The company's latest EPS is USD -1.7125 and P/E is -1.68.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 55k | 0 | 0 |
| Operating Income | -4.75M | -4.56M | -5.23M | -7.73M | -4.89M |
| Net Income | -4.56M | -4.68M | -5.14M | -7.69M | -4.72M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 41k | 29k | 196k | 140k | 55k |
| Operating Income | -2.1M | -3.48M | -13.8M | -17.78M | -22.25M |
| Net Income | -2.19M | -3.58M | -13.86M | -17.59M | -22.11M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 28.33M | 24.1M | 21.32M | 18.26M | 14.1M |
| Total Liabilities | 5.66M | 5.22M | 6.18M | 7.17M | 6.77M |
| Total Equity | 22.66M | 18.88M | 15.14M | 11.09M | 7.33M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 660k | 9.6M | 38.99M | 24.1M | 18.61M |
| Total Liabilities | 1.11M | 3.4M | 4.17M | 5.22M | 6.03M |
| Total Equity | -450k | 6.2M | 34.82M | 18.88M | 12.58M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -10.79M | -14.69M | -4.22M | -9.24M | -13.21M |
| Investing | -14.91M | -14.78M | 2.11M | 5.15M | 7.08M |
| Financing | -57k | -79k | 748k | 2.95M | 3.08M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.87M | -3.24M | -12.37M | -14.69M | -18.87M |
| Investing | -14k | -21k | -94k | -14.78M | 10.22M |
| Financing | 1.75M | 10.49M | 41.77M | -79k | 12.64M |
| Market Cap | 37.31M |
| Price to Earnings Ratio | -1.68 |
| Price to Sales Ratio | 669.77 |
| Price to Cash Ratio | 3.15 |
| Price to Book Ratio | 2.96 |
| Dividend Yield | - |
| Shares Outstanding | 12.91M |
| Average Volume (1 week) | 86.4k |
| Average Volume (1 Month) | 87k |
| 52 Week Change | -44.95% |
| 52 Week High | 5.65 |
| 52 Week Low | 2.00 |
| Spread (Intraday) | 0.03 (1.03%) |
| Company Name | Gain Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.gaintherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
